Aspire Biopharma Holdings, INC. (ASBPW) — S-1 Filings
All S-1 filings from Aspire Biopharma Holdings, INC.. Browse 4 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (4)
-
Aspire Biopharma Files S-1 for 41.5M Share Resale, Eyes $100M ELOC Funding
— Dec 3, 2025 Risk: high
Aspire Biopharma Holdings, Inc. (ASBPW) filed an S-1 on December 3, 2025, primarily for the resale of up to 41,500,000 shares of common stock by Arena Business -
Aspire Biopharma Registers 147M Shares for Resale, Seeks Reverse Split Nod
— Sep 18, 2025 Risk: high
Aspire Biopharma Holdings, Inc. (ASBPW) filed an S-1 on September 18, 2025, to register the resale of up to 147,177,424 shares of common stock underlying Conver -
Aspire Biopharma Files S-1 for Public Offering
— May 13, 2025 Risk: medium
Aspire Biopharma Holdings, Inc. filed an S-1 form on May 13, 2025, indicating its intention to become a publicly traded company. The company, previously known a -
Aspire Biopharma Files S-1 for Securities Registration
— Apr 9, 2025 Risk: medium
Aspire Biopharma Holdings, Inc. filed an S-1 form on April 9, 2025, to register securities. The company, previously known as PowerUp Acquisition Corp., is incor
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX